Correction: Gubič et al. Design of New Potent and Selective Thiophene-Based KV1.3 Inhibitors and Their Potential for Anticancer Activity. Cancers 2022, 14, 2595

Author:

Gubič Špela1ORCID,Hendrickx Louise Antonia2,Shi Xiaoyi3,Toplak Žan1ORCID,Možina Štefan1ORCID,Theemsche Kenny M. Van45,Pinheiro-Junior Ernesto Lopes2ORCID,Peigneur Steve2ORCID,Labro Alain J.45ORCID,Pardo Luis A.3ORCID,Tytgat Jan2,Tomašič Tihomir1ORCID,Peterlin Mašič Lucija1ORCID

Affiliation:

1. Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia

2. Campus Gasthuisberg, University of Leuven, Toxicology and Pharmacology, Onderwijs en Navorsing 2, Herestraat 49, 3000 Leuven, Belgium

3. AG Oncophysiology, Max-Planck Institute for Multidisciplinary Sciences, Hermann-Rein-Str. 3, 37075 Göttingen, Germany

4. Laboratory for Molecular, Cellular and Network Excitability, Department of Biomedical Sciences, University of Antwerp, 2610 Wilrijk, Belgium

5. Department of Basic and Applied Medical Sciences, Ghent University, Corneel Heymanslaan 10 (Entrance 36), 9000 Ghent, Belgium

Abstract

In the original publication [...]

Funder

Slovenian Research Agency

Publisher

MDPI AG

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3